William Bradley - 10 Jun 2026 Form 4 Insider Report for FRACTYL HEALTH, INC. (GUTS)

Reporting relationship: Director
Issuer ticker: GUTS
Reported as of: 10 Jun 2026
Net transaction value: +$50,329
SEC form: 4
Accepted by SEC: 11 Jun 2026, 17:04:39 UTC
Prior SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact

Key filing fact

William Bradley filed Form 4 for FRACTYL HEALTH, INC. (GUTS) on 11 Jun 2026.

Key facts

This page summarizes William Bradley's Form 4 filing for FRACTYL HEALTH, INC. (GUTS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 11 Jun 2026, 17:04.

Change

Previous filing in this sequence was filed on 13 Jun 2025.
Current net transaction value: +$50,329.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001177319 Primary reporting owner

BRADLEY WILLIAM

Relationship: Director
Address: 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON
Signature: /s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact
Signature date: 11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GUTS transaction

Common Stock

Purchase

Transaction value: $50,329
Shares: +68,493
Change %: +425%
Price: $0.7348
Shares after: 84,622
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GUTS transaction Derivative

Stock Option

Award

Transaction value
Shares: +22,500
Change %
Price: $0.000000^*
Shares after: 22,500
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,500
Exercise price: $0.7318
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Open market purchase.

Footnote F2

The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.